Literature DB >> 22030453

Direct, simultaneous measurement of liposome-encapsulated and released drugs in plasma by on-line SPE-SPE-HPLC.

Eiichi Yamamoto1, Kenji Hyodo, Naozumi Ohnishi, Takuya Suzuki, Hiroshi Ishihara, Hiroshi Kikuchi, Naoki Asakawa.   

Abstract

A method for the simultaneous measurement of liposome-encapsulated and released drugs in mouse plasma by on-line solid phase extraction (SPE)-SPE-HPLC with direct plasma injection was developed using a doxorubicin (DXR)-containing liposome formulation as the model drug. During SPE, the released DXR was extracted on the 1st restricted-access media (RAM) SPE column, whereas the liposomes were eluted. The eluted liposomes were collapsed on-line, and the released DXR was delivered to the 2nd RAM SPE column for extraction. The retained DXR on the SPE columns was analyzed via HPLC-fluorescent detector by switching the valves. The method was validated and applied to the pharmacokinetic study of DXR in mice after intravenous injection of DXR-containing liposomes. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030453     DOI: 10.1016/j.jchromb.2011.10.004

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Simulation of Stimuli-Responsive and Stoichiometrically Controlled Release Rate of Doxorubicin from Liposomes in Tumor Interstitial Fluid.

Authors:  Eiichi Yamamoto; Kenji Hyodo; Takuya Suzuki; Hiroshi Ishihara; Hiroshi Kikuchi; Masaru Kato
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

2.  Insights on Ultrafiltration-Based Separation for the Purification and Quantification of Methotrexate in Nanocarriers.

Authors:  Sara S Marques; Inês I Ramos; Sara R Fernandes; Luisa Barreiros; Sofia A C Lima; Salette Reis; M Rosário M Domingues; Marcela A Segundo
Journal:  Molecules       Date:  2020-04-18       Impact factor: 4.411

Review 3.  Mapping of the available standards against the regulatory needs for nanomedicines.

Authors:  Blanka Halamoda-Kenzaoui; Uwe Holzwarth; Gert Roebben; Alessia Bogni; Susanne Bremer-Hoffmann
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-06-20

4.  Development of a method to quantify total and free irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) for pharmacokinetic and bio-distribution studies after administration of irinotecan liposomal formulation.

Authors:  Wenqian Yang; Zimeng Yang; Jieru Liu; Dan Liu; Yongjun Wang
Journal:  Asian J Pharm Sci       Date:  2018-09-11       Impact factor: 6.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.